TCG News

Dr. Hui Tian joins The Column Group as Venture Partner

The Column Group announces the hiring of Dr. Hui Tian. Previously, Dr. Tian was a founding member of NGM Biopharmaceuticals and most recently served as Senior Vice President of Research. In this role, he was responsible for discovery research across multiple therapeutic areas including metabolic diseases, retinal diseases and cancer.  In a span of 14 …

Dr. Hui Tian joins The Column Group as Venture Partner Read More »

TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow

Widely considered to be the father of the biotechnology industry, Robert Swanson changed the world when he founded Genentech with Herbert Boyer in 1976. TCG’s new fellowship program pays homage to Robert Swanson’s legacy, empowering the next generation of young visionaries on their quest to better the world through science and medicine. The Column Group …

TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow Read More »

TCG Announces the Addition of TCG iPartners

TCG’s iPartners represents a new ideation advisory group comprised of leading academic investigators and biotech entrepreneurs. Working closely with TCG’s Swanson Fellows and our core investment team, this group is dedicated to crafting innovative new drug discovery company concepts, drawing on their deep scientific expertise, academic and industry networks, and entrepreneurial intuition. The iPartners consist …

TCG Announces the Addition of TCG iPartners Read More »

Scroll to Top